Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bravuron Z
- Development stage
- Unknown
- Lead developer
- Wonne International
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Bravuron Z is a multivitamin and multimineral dietary supplement formulated with grape seed extract, essential vitamins, and minerals. Developed by Wonne International, it is designed to support overall health, boost immunity, and fulfill daily nutritional requirements. The formulation contains grape seed extract, vitamin C, vitamin B3 (niacinamide), vitamin E, magnesium, vitamin B5 (pantothenic acid), vitamin B6, vitamin B1 (thiamine), and zinc. It is marketed as an oral tablet to promote cellular health, enhance energy levels, and provide antioxidant protection.
- Brand names
- Bravuron Z
- Other names
- Bravuron Z Multivitamin & Multimineral Tablets with Grape Seed Extract
Beyond the preview
Go deeper on Bravuron Z.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bravuron Z.